| Dr Gary Robert Clauss Jr, DO | |
|
2500 Bernville Rd, Reading, PA 19605-9453 | |
| (610) 378-2000 | |
| Not Available |
| Full Name | Dr Gary Robert Clauss Jr |
|---|---|
| Gender | Male |
| Speciality | Family Medicine |
| Location | 2500 Bernville Rd, Reading, Pennsylvania |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1427613157 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | HS000214L (Pennsylvania) | Primary |
| Entity Name | Penn State Health Community Medical Group Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1861988644 PECOS PAC ID: 8729351077 Enrollment ID: O20170907002279 |
News Archive
After the killing last year of George Floyd, a Black man, by a white Minneapolis police officer, Wisconsin Gov. Tony Evers declared racism a public health crisis. The governors of Michigan and Nevada quickly followed, as have legislative bodies in Minnesota, Virginia and Washington, D.C.
Acupuncture does not appear to aid in stroke recovery, according to a new study published in CMAJ. This study, perhaps the most comprehensive to date as it includes trials published in English language and Asian journals, was a systematic review conducted by researchers in South Korea and the United Kingdom.
The crunch of helmets as players tangle for a loose football, the swoosh of the net as an outside jumper is made and the crack of the bat as a guaranteed double sails into right center field are awesome sounds to sports fans but for dentists, they're reminders that a player is just one misstep away from a dental injury.
Nymox Pharmaceutical Corporation announced today that it has been awarded a grant of $244,479.25 from the U.S Government under the Qualifying Therapeutic Discovery Project for its ongoing Phase III clinical trial program for NX-1207 for the treatment of benign prostatic hyperplasia (BPH). The grant was the maximum allowable for an individual development program.
QLT Inc. today announced that QLT091001, the Company's oral synthetic retinoid, has been granted orphan drug designation for the treatment of Retinitis Pigmentosa (RP) from the U.S. Food and Drug Administration (FDA). This follows the FDA grant of orphan drug designation for QLT091001 for the treatment of Leber Congenital Amaurosis (LCA) also on December 7, 2010.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Gary Robert Clauss Jr, DO 1221 Mount Vernon St Apt 216, Philadelphia, PA 19123-3385 Ph: (860) 367-6387 | Dr Gary Robert Clauss Jr, DO 2500 Bernville Rd, Reading, PA 19605-9453 Ph: (610) 378-2000 |
News Archive
After the killing last year of George Floyd, a Black man, by a white Minneapolis police officer, Wisconsin Gov. Tony Evers declared racism a public health crisis. The governors of Michigan and Nevada quickly followed, as have legislative bodies in Minnesota, Virginia and Washington, D.C.
Acupuncture does not appear to aid in stroke recovery, according to a new study published in CMAJ. This study, perhaps the most comprehensive to date as it includes trials published in English language and Asian journals, was a systematic review conducted by researchers in South Korea and the United Kingdom.
The crunch of helmets as players tangle for a loose football, the swoosh of the net as an outside jumper is made and the crack of the bat as a guaranteed double sails into right center field are awesome sounds to sports fans but for dentists, they're reminders that a player is just one misstep away from a dental injury.
Nymox Pharmaceutical Corporation announced today that it has been awarded a grant of $244,479.25 from the U.S Government under the Qualifying Therapeutic Discovery Project for its ongoing Phase III clinical trial program for NX-1207 for the treatment of benign prostatic hyperplasia (BPH). The grant was the maximum allowable for an individual development program.
QLT Inc. today announced that QLT091001, the Company's oral synthetic retinoid, has been granted orphan drug designation for the treatment of Retinitis Pigmentosa (RP) from the U.S. Food and Drug Administration (FDA). This follows the FDA grant of orphan drug designation for QLT091001 for the treatment of Leber Congenital Amaurosis (LCA) also on December 7, 2010.
› Verified 9 days ago
Dr. Robin E. Savar, D.O. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 3970 Perkiomen Ave, Suite 102, Reading, PA 19606 Phone: 610-779-1330 Fax: 610-779-7699 | |
Mark Elliot Wagner, D.O. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 623 North 5th Street, Reading, PA 19601 Phone: 610-374-8585 Fax: 610-374-2574 | |
Joseph Kang, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 131 N 5th St, Reading, PA 19601 Phone: 610-375-8507 Fax: 610-374-5249 | |
Dr. Thomas Hanz Noller, MD Family Medicine Medicare: Medicare Enrolled Practice Location: 526 Penn St, Ste 2, Reading, PA 19602 Phone: 610-375-3000 Fax: 610-898-1149 | |
Leslie Marie Lazore-mack, DO Family Medicine Medicare: Medicare Enrolled Practice Location: 1903 Morgantown Rd, Reading, PA 19607 Phone: 610-777-4040 Fax: 610-777-5575 | |
Pearl N Pakdi, MD Family Medicine Medicare: Medicare Enrolled Practice Location: 2500 Bernville Rd, Reading, PA 19605 Phone: 610-378-2000 Fax: 610-378-2799 | |
Claire Murphy, MD Family Medicine Medicare: Medicare Enrolled Practice Location: 400 Saint Bernardine St, Alvernia University, Health & Wellness Center, Veronica, Reading, PA 19607 Phone: 610-568-1467 Fax: 610-796-8422 |